SINGAPORE (Sept 8): CIMB Research is initiating coverage of CEI Limited at “add” with a target price of $1.04, with expectations that its medical technology (medtech) and life science business will drive revenue growth of 5% over the FY17-18 forecast period.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $4.99/month*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply